IL1B and COVID-19: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), leading to complex immune responses [1,2] that involve the release of several inflammatory cytokines/chemokines [1,3,4,5,6,7,8], especially interleukin-1beta (IL-1β) [9] and IL-6, often referred to as “cytokine exacerbated production” [3,10,11].